Fig. 6
From: Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death
The influence of pharmacological inhibitor on ECGs during cardiac reperfusion. Representative ECG traces from rats in control (A), empagliflozin (B), control with U0126 (C), and empagliflozin with U0126 (D) groups during the cardiac reperfusion period. CON, control; VT, ventricular tachycardia; First episode of VT, showing the first run of VT; AVB, AV block; PVT, polymorphic VT, VF, ventricular fibrillation, Sinus, rat in sinus rhythm